The
global needle-free drug delivery devices market is anticipated to grow at a considerable CAGR of 14.5% during the forecast period. The key players are developing and launching new devices and using new technology to deliver virtually painless injections, which is positively surging the demand of the market. For instance, in September 2021, Scientists developed a three-dimensional (3D) printed vaccine patch that provides greater protection than a typical immunization shot. The technique uses 3D-printed microneedles lined up on a polymer patch and barely long enough to reach the skin to deliver the vaccine. The ease and effectiveness of the new vaccine may lead to a new way to deliver vaccines that is painless, less invasive than a shot with a needle, and can be self-administered. The resulting immune response from the patch was 10 times greater than the vaccine delivered into an arm muscle with a needle jab.
Browse the full report description of “Global Needle-Free Drug Delivery devices Market Size, Share, and Trends Analysis Report by Technology (Inhaler Technology, Jet Injectors, Transdermal Patch Technology, and Other Technologies), and by Application (Pain Management, Insulin Delivery, Vaccine Delivery, Pediatric Injections, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/needle-free-drug-delivery-devices-market-size
Moreover, in October 2021, Dentapen is an innovative new way launched by Septodont to provide a pain-free injection experience for their patients. Septodont’s Dentapen injection gives a constant flow, at the right place. This then allows the dentist time to focus more on needle insertion, leading to better control of the injection and a reduction in pain for the patient. Clinicians can hold it in two different ways – by the wings, like a manual syringe, or pen-like, for a precise injection during special procedures. Dentapen has reduced challenges such as Variations in pressure, which can damage tissue and cause discomfort to the patient, and Keeping the quality of injections consistent throughout the day.
Additionally, in October 2021, Researchers in the Netherlands are working together to develop laser technology to enable "virtually painless" injections without needles, which will ease fear and lower the threshold for vaccinations. The Bubble Gun is still a work in progress and could take 1-3 years before it is available to the general public. Bubble Gun uses a laser to push tiny droplets through the outer layer of the skin and the process is quicker than a mosquito bite and "should not cause pain", as nerve endings in the skin are not touched.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Technology
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GlaxoSmithKline PLC, Mika Medical Co., Novartis International AG, Pharma Jet, Inc., Portal Instruments, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Needle-Free Drug Delivery Devices Market Report Segment
By Technology
• Inhaler Technology
• Jet Injectors
• Transdermal Patch Technology
• Other Technologies
By Application
• Pain Management
• Insulin Delivery
• Vaccine Delivery
• Pediatric Injections
• Others
Global Needle-Free Drug Delivery Devices Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa